OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 5

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 89.4% 2,210,096 2,472,862 87.6% 1.7%
Sex Female 90.1% 1,136,632 1,261,582 88.4% 1.7%
Male 88.6% 1,073,464 1,211,280 86.8% 1.8%
Ethnicity White - British 93.2% 1,350,650 1,448,937 91.6% 1.7%
White - Irish 87.1% 13,601 15,624 85.7% 1.4%
White - Any other White background 66.4% 52,612 79,226 64.8% 1.6%
Mixed - White and Black Caribbean 65.4% 2,079 3,178 63.2% 2.2%
Mixed - White and Black African 65.9% 1,694 2,569 64.3% 1.6%
Mixed - White and Asian 82.7% 2,114 2,555 80.8% 1.9%
Mixed - Any other mixed background 74.8% 3,703 4,949 73.0% 1.8%
Asian or Asian British - Indian 87.0% 43,806 50,323 85.9% 1.2%
Asian or Asian British - Pakistani 71.5% 17,878 25,004 69.0% 2.5%
Asian or Asian British - Bangladeshi 82.4% 5,103 6,195 79.5% 2.8%
Asian or Asian British - Any other Asian background 81.0% 18,193 22,463 79.5% 1.5%
Black or Black British - Caribbean 57.7% 8,638 14,959 55.3% 2.4%
Black or Black British - African 61.2% 9,338 15,267 58.6% 2.6%
Black or Black British - Any other Black background 63.9% 2,331 3,647 61.8% 2.1%
Other ethnic groups - Chinese 71.1% 6,685 9,408 69.3% 1.7%
Other ethnic groups - Any other ethnic group 67.8% 8,995 13,258 66.1% 1.8%
Patients with any other ethnicity code 90.3% 295,848 327,453 88.5% 1.9%
Ethnicity not stated 84.1% 12,684 15,085 82.0% 2.0%
Ethnicity not recorded 85.8% 354,046 412,664 83.9% 1.9%
Ethnicity (broad categories) White 91.8% 1,416,870 1,543,801 90.1% 1.6%
Mixed 72.5% 9,611 13,258 70.5% 2.0%
South Asian 81.7% 84,994 103,999 80.1% 1.7%
Black 60.0% 20,321 33,887 57.5% 2.4%
Other 69.2% 15,687 22,666 67.5% 1.7%
Unknown 87.7% 662,599 755,216 85.8% 1.9%
Index of Multiple Deprivation 1 (most deprived) 82.8% 305,088 368,403 80.2% 2.6%
2 86.5% 382,613 442,505 84.4% 2.1%
3 90.0% 472,045 524,734 88.2% 1.7%
4 91.8% 506,275 551,642 90.4% 1.4%
5 (least deprived) 93.1% 524,790 563,983 91.8% 1.2%
Unknown 89.4% 19,278 21,560 87.5% 1.9%
Clinical Risk Groups Patients in Any Clinical Risk Group 91.1% 825,013 905,709 89.4% 1.7%
Patients with Immunosuppression 92.9% 35,007 37,674 91.4% 1.5%
Patients with CKD 92.1% 107,520 116,683 90.5% 1.6%
Patients who have Chronic Respiratory Disease 91.0% 87,878 96,572 89.2% 1.8%
Patients with Diabetes 90.7% 295,288 325,458 89.0% 1.7%
Patients with Chronic Liver disease 90.4% 66,493 73,591 88.6% 1.8%
Patients with CNS Disease (including Stroke/TIA) 91.0% 123,060 135,163 89.2% 1.9%
Patients with Chronic heart disease 91.9% 345,030 375,452 90.2% 1.7%
Patients with Asplenia or Dysfunction of the Spleen 93.6% 13,258 14,168 92.3% 1.2%
Patients with Wider Learning Disability 84.6% 4,914 5,810 79.9% 4.7%
Patients with Severe Mental Health 79.8% 18,949 23,758 76.9% 2.9%
Other Groups Patients with Morbid Obesity 90.6% 70,749 78,113 88.5% 2.1%
Patients who are pregnant 91.7% 231 252 88.9% 2.8%